SEC Form 4 · accession 0001140361-15-024784
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Bate
Director
Period of report
Jun 10, 2015
Accepted (ET)
Jun 18, 2015 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 10, 2015 | A | 1,100 | — | A | 11,875 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F3 | $122.27 | Jun 10, 2015 | A | 3,300 | A | Sep 10, 2015 | Jun 9, 2025 | Common Stock | 3,300 | 3,300 | D |
Explanation of responses
- F1This transaction, originally due to be reported on Friday, June 12, 2015, is being reported late due to an administrative oversight.
- F2Restricted stock units granted on June 10, 2015. Price not applicable.
- F3Option grant vests 1/4 on September 10, 2015 and 1/4th every 90 days thereafter.